Single-dose study of a corticotropin-releasing factor receptor-1 antagonist in women with 21-hydroxylase deficiency

Article

Abstract: Context: Treatment of 21-hydroxylase deficiency (21OHD) is difficult to optimize. Normalization of e

Palabras claves:

Autores:

Farber R.H., Grigoriadis D.E., Luo R., Madrigal D., Muth T., O'Brien C.F., Ramm C.A., Richard J. Auchus, Spencer-Segal J.L., Turcu A.F.

Fuentes:

scopus